Literature DB >> 32491198

Randomization-based interval estimation in randomized clinical trials.

Yanying Wang1, William F Rosenberger1.   

Abstract

Randomization-based interval estimation takes into account the particular randomization procedure in the analysis and preserves the confidence level even in the presence of heterogeneity. It is distinguished from population-based confidence intervals with respect to three aspects: definition, computation, and interpretation. The article contributes to the discussion of how to construct a confidence interval for a treatment difference from randomization tests when analyzing data from randomized clinical trials. The discussion covers (i) the definition of a confidence interval for a treatment difference in randomization-based inference, (ii) computational algorithms for efficiently approximating the endpoints of an interval, and (iii) evaluation of statistical properties (ie, coverage probability and interval length) of randomization-based and population-based confidence intervals under a selected set of randomization procedures when assuming heterogeneity in patient outcomes. The method is illustrated with a case study.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Monte Carlo re-randomization test; Robbins-Monro algorithm; bisection method; interval estimation; randomization-based inference

Mesh:

Year:  2020        PMID: 32491198     DOI: 10.1002/sim.8577

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  2 in total

1.  Assessing intervention effects in a randomized trial within a social network.

Authors:  Shaina J Alexandria; Michael G Hudgens; Allison E Aiello
Journal:  Biometrics       Date:  2021-11-26       Impact factor: 1.701

2.  Discussion on "Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment for binary, ordinal, and time-to-event outcomes".

Authors:  Michael A Proschan
Journal:  Biometrics       Date:  2021-06-09       Impact factor: 1.701

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.